All tested P13K inhibitors showed synergistic effects with palbociclib when the growth inhibition was below 50%, with copansilib being the most effective.[40] The combinations shown to reduce the AML-FLT3-positive cell proliferation in a dose-dependent manner and prolonged treatment showed no sign of resistance. This evidence concerns the gene FLT3 and acute myeloid leukemia.